Zentek (STU:ZAY) EBIT per Share: €-0.06 (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:ZAY Zentek Ltd STU:ZAY
30 GF Score
Price €0.41
! 6 Warning Signs
View Full Analysis

What is Zentek EBIT per Share?

Zentek STU:ZAY -2.84% 30 EBIT per Share is €-0.06 as of Mar. 2026. GuruFocus rates STU:ZAY with a GF Score™ of 30/100. The stock has 6 warning signs investors should review. Among 686 Medical Devices & Instruments companies, Zentek ranks better than 56.71% on this metric.

Zentek's EBIT per Share for the three months ended in Mar. 2026 was €-0.02. Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 was €-0.06.

During the past 3 years, the average EBIT per Share Growth Rate was 13.80% per year. During the past 5 years, the average EBIT per Share Growth Rate was -6.60% per year. During the past 10 years, the average EBIT per Share Growth Rate was -13.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Zentek's EBIT per Share or its related term are showing as below:

STU:ZAY' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -91.3   Med: -1.5   Max: 23
Current: 13.8

During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Zentek was 23.00% per year. The lowest was -91.30% per year. And the median was -1.50% per year.

STU:ZAY's 3-Year EBIT Growth Rate is ranked better than
56.71% of 686 companies
in the Medical Devices & Instruments industry
Industry Median: 9.25 vs STU:ZAY: 13.80

Zentek's EBIT for the three months ended in Mar. 2026 was €-2.18 Mil.

Zentek  (STU:ZAY) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Zentek EBIT per Share Related Terms

Zentek EBIT per Share Historical Data

* Premium members only.

The historical data trend for Zentek's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zentek EBIT per Share Chart

Zentek Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
EBIT per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.25 -0.10 -0.08 -0.06 -0.06

Zentek Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBIT per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.01 -0.01 -0.01 -0.01 -0.02
STU:ZAY
30GF Score
Zentek Ltd STU:ZAY
EBIT per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Zentek EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Zentek's EBIT per Share for the fiscal year that ended in Mar. 2026 is calculated as

EBIT per Share(A: Mar. 2026 )
=EBIT/Shares Outstanding (Diluted Average)
=-5.996/105.920
=-0.06

Zentek's EBIT per Share for the quarter that ended in Mar. 2026 is calculated as

EBIT per Share(Q: Mar. 2026 )
=EBIT/Shares Outstanding (Diluted Average)
=-2.182/107.606
=-0.02

EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.06

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT per Share →
What does a EBIT per Share of €-0.06 mean?
Zentek (STU:ZAY) has a EBIT per Share of €-0.06 as of Mar. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Zentek and its competitors. According to the industry distribution chart, Zentek ranks #297 out of 686 companies in the Medical Devices & Instruments industry, placing it in the top 43.3%.
Is Zentek's EBIT per Share too high?
Zentek's current EBIT per Share is €-0.06. Based on the distribution chart, Zentek ranks #297 out of 686 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Zentek has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Zentek's EBIT per Share compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Zentek ranks #297 out of 686 companies for EBIT per Share. This puts Zentek in the upper half of its industry. The industry median EBIT per Share is 9.25. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Medical Devices & Instruments company?
The median EBIT per Share among Medical Devices & Instruments companies is 9.25, based on 686 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Zentek and its competitors. For the Medical Devices & Instruments industry, the median EBIT per Share is 9.25 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Zentek's current EBIT per Share is €-0.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zentek stock overvalued right now?
Zentek (STU:ZAY) has a current EBIT per Share of €-0.06. The current EBIT per Share is €-0.06. Zentek's overall GF Score™ is 30/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Zentek (STU:ZAY), the current EBIT per Share is €-0.06 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Zentek Business Description

Other Exchanges ZTEK:USAZEN:Canada
Address 24 Corporate Court, Guelph, ON, CAN, N1G 5G5
Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection, and treatment. It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases.
30GF Score

Get the complete analysis for STU:ZAY

EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.41
Price